Intranasal lidocaine for acute migraine: A meta-analysis of randomized controlled trials.
Pei-Wen ChiKun-Yi HsiehKuan-Yu ChenChin-Wang HsuChyi-Huey BaiChiehfeng ChenYuan-Pin HsuPublished in: PloS one (2019)
Intranasal lidocaine can be considered a useful option for patients with an acute migraine. It yields a high success rate, a low pain intensity, an infrequent need for rescue medicine, and tolerable adverse events. The administration of antiemetics is an important confounding factor.